Navigation Links
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Date:8/19/2007

NEW HAVEN, Conn., Aug. 15 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) today announced that it had accrued a total of 85 patients to the pivotal Phase II trial of its lead anticancer agent Cloretazine(R) (VNP40101M) in previously untreated elderly patients with de novo poor-risk acute myelogenous leukemia (AML).

Alan Kessman, Chief Executive Officer said, "We are extremely pleased to have reached this milestone in the pivotal Phase II trial of our lead anticancer agent. We will now proceed to analyze the data and, if warranted, prepare a New Drug Application for submission to the U.S. Food and Drug Administration in 2008." He added, "We continue to plan on the release of preliminary data from this trial at the American Society of Hematology (ASH) Meeting in December."

The pivotal Phase II trial, initiated in May 2006, is evaluating Cloretazine(R) (VNP40101M) as a single agent in previously untreated AML patients over the age of 60 with de novo poor-risk AML. Patients are eligible for this trial if they are at least 60 years of age with de novo AML and have one of the following additional risk factors: (i) unfavorable cytogenetics; (ii) an ECOG performance status of 2 or greater; or (iii) a co-morbid condition that precludes them from receiving cytotoxic therapy with cytarabine and an anthracycline. Patients over the age of 70 with de novo AML who do not have favorable cytogenetics are also eligible.

The primary endpoint for this trial is the complete response rate (including complete remission (CR) and complete remission with incomplete platelet recovery (CRp)). Secondary endpoints include overall survival, disease-free survival and progression-free survival.

The trial ha
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 24, 2013 3SBio Inc. (NASDAQ: ... a leading China -based biotechnology ... biopharmaceutical products, announced today that, at an extraordinary ... shareholders voted in favor of the proposal to ... plan of merger dated February 8, 2013, among ...
(Date:5/23/2013)... BRAINTREE, Mass. , May 23, 2013  Haemonetics Corporation ... Chris Lindop , CFO & EVP-Business Development, will present ... Care Conference in Boston, MA on ... (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may ... About Haemonetics Haemonetics (NYSE: ...
(Date:5/23/2013)...  TeamHealth Medical Call Center (THMCC), a premier ... lines, announces its newly formed Clinical Advisory Committee. ... leaders, provides clinical expertise to advance THMCC,s purpose ... hospital clients, physician clients and patients. ... imperative to continuously advance our services and improve ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3TeamHealth Medical Call Center Forms Clinical Advisory Committee 2
... BabyPing will unveil a new high ... - CES - this week. The new BabyPing high security ... their infant on iPhone, iPad or iPod Touch through cutting edge ... truly reassuring alternative to old-style monitors by using the latest in ...
... 2012 /PRNewswire-Asia/ -- The Ministry of Health and Welfare and ... referred from the Health Authority-Abu Dhabi (HAAD) arrived in South ... The Korean government arranged for domestic hospitals to sign ... Dhabi when HAAD Chairman Mohammed Sultan Al Hameli and CEO ...
Cached Medicine Technology:BabyPing Wi-Fi Baby Monitor for iOS Debuts at CES - the Next Generation of Baby Monitor is Here 2First Patient from Abu Dhabi Arrives in South Korea for Medical Treatment 2
(Date:5/25/2013)... California (PRWEB) May 25, 2013 While ... honoring those who have died serving our Country, many ... with prolonged partying and recklessness. The DUI attorneys at ... Weekend DUI checklist to help keep this weekend’s party-goers ... Records System , there were more than 950 fatal ...
(Date:5/25/2013)... Life science and analytical reagents are ... and create a new substance with the purpose of ... known as biotechnology reagents. Such reagents are significant in ... This market is driven by factors such as expansion ... therapeutics, growth in research and rapid commercialization of such ...
(Date:5/25/2013)... News) -- Many viruses and parasites that affect both ... a bacteria-borne illness than can result in liver or ... according to a veterinarian. These germs could ... air, said Dr. Susan Nelson, a clinical associate professor ... these serious diseases can be fatal, even with treatment," ...
(Date:5/25/2013)... Dallas, TX (PRWEB) May 25, 2013 ... between those who are carrying excessive weight and their ... that for many, simply losing weight can naturally relieve ... Medicine found that improvement in sleep quality was significantly ... this six month study dated November 6th, ...
(Date:5/25/2013)... 25, 2013 Pradaxa lawsuits ... episodes of internal bleeding while using the blood thinner continue ... Court, Southern District of Illinois, Bernstein Liebhard LLP reports. ... side effect claims had been filed in the ... 705 claims reported by the Court on May 15th. ( ...
Breaking Medicine News(10 mins):Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 3Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Hidden Dangers Dog Dog Parks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3
... States (OECS) have said schools// of member-countries will add ... ,Arsen James, education minister of St. Lucia, said the ... region where, according to UN statistics, the year 2006 ... ,Nehum Jn Baptiste, director of St. Lucia ...
... in India suffering from serious hearing problems could have been ... such surgery is keeping them away, health experts said Saturday. ... kind of hearing problems and about a million are children ... high cost of the device is proving a hindrance," said ...
... prisoner from Ireland has reportedly succumbed to Legionnaires’ disease. // ... treatment where a test revealed the presence of the bacteria ... disease is a rare form of pneumonia. It takes its ... hotel that was hosting a convention of the Pennsylvania Department ...
... Eating more than 340 grams of omega-3-rich seafood per ... quotient (IQ) scores// in the children, says a new ... goes against recommendations of seafood consumption during pregnancy, which ... per week to avoid exposing the foetus to trace ...
... Family Health Survey, half the children’s population// in India is ... third one since 1992-1993. ,On a comparative ... is 62% while it is 42% in urban regions. Underweight ... only 8%. On the nutrition front, it is as poor ...
... frolicking to their heart's content, brave young hearts battling cancer ... send the message - the disease is curable. ... Child Cancer Day. ,Prabhasimran Anand, a bubbly eight-year-old, ... with balloons: "I am fighting blood cancer. I also go ...
Cached Medicine News:Health News:Need for Cost-effective Hearing Implants 2Health News:Convict Felled by Legionnaires 2Health News:Fish Intake Linked to Higher IQ in Offspring 2Health News:Spirited, Smiling Young Warriors Take on Cancer 2
... foremost source of current natural ... professionals together with A to ... Drug Interaction checking. Includes free ... is the ideal drug reference ...
Instant access to drug-drug and drug-food interaction between thousands of brand and generic drugs plus A to Z Drug Facts monographs. Includes free updates for one year....
... The Concise Guide to Drug Interaction Principles ... written expressly for clinicians. , An understanding ... the practice of medicine. Since publication of ... in 2001, our increasing pharmacopoeia - coupled ...
... to use drug information reference ... protocols with patient care guidelines., ... more than 4,700 drugs, including ... the latest indications, dosages, side ...
Medicine Products: